Onconomics Extracts +

Drug efficacy

Onconomics Extracts+ provides highly detailed and accurate information about how effective specific natural substances and plant extracts are, as anticancer agents as well as the gene expression profile of genes, associated with fundamental biological processes. This includes processes such as angiogenesis, cell cycle regulation, self-repair, metastasis, apoptosis, proliferation etc.

Circulating tumor cells are isolated from a peripheral blood sample and then used for different assays. The results provide a comprehensive and highly personalized analysis of the most effective natural treatments that patients can use to treat their cancer, alongside conventional therapies.

Natural substances and extracts that are tested are divided into Class-I (Cytotoxic agents), Class-II (Immunostimulants / immunomodulators), and Class-III (PK inhibitors).

Test details

Sample type

Blood or tissue for Central Nervous System Primary Tumors

Analysis period

Approx. 7 days

Cancer type

Applicable for all cancer types

Final results

7-10 days after sample delivery

Sample size

15-25 ml peripheral whole blood. Tissue sample: Minimum 400mg.

Price*

1750 €

* The prices of the tests may be an issue of local additional taxes and value added taxes which are dependent of each country’s legislation. The prices may vary in areas that are under the jurisdiction of a distributor. These prices are for the tests only, and they do not include in-office fees such as consultation, blood draws, etc.

* RGCC is not liable for any third-party comments or claims regarding our products. For accurate and up-to-date information about our offerings, please refer to our official website: rgcc-international.com

 

Use our "intelligent filter" to find out which test is most suitable for your patients.